Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...

SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced it will present data from three in vitro dissolution studies exploring the dissolution performance ...

(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution, ...

Torrent Pharmaceuticals Limited has voluntarily recalled a drug used to treat blood cell disorders. One lot of anagrelide capsules were recalled, according to an announcement with the U.S. Food and ...

The FDA released an announcement for a voluntary national recall of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K on Tuesday, June 25th. Glenmark Pharmaceuticals Inc., USA, ...

American Health Packaging on behalf of BluePoint Laboratories is voluntarily recalling 21 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K, to the consumer level. The ...

More than 130 batches of potassium chloride capsules, prescribed to those with hypokalaemia, have been recalled for a dissolution issue that could elevate potassium to life-threatening levels, ...

Ill-dissolving capsules can hamper drugs’ effectiveness or render them useless, which is especially concerning when they’re used to treat seriously sick blood disorder patients. Teva Pharmaceuticals ...

At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K due ...

Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary ...